Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 3/20 | 0.57 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.57 |
| ▸ | IKZF2 | Q9UKS7 | 14/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.40 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22526509 | 0.91 | DDB1 (0.58) | DDB1CRBNIKZF2DRD2SLC6A4 | |
| SCHEMBL23541166 | 0.90 | DDB1 (0.57) | DDB1CRBNIKZF2DRD2SLC6A4 | |
| SCHEMBL22526963 | 0.90 | DDB1 (0.55) | DDB1CRBNIKZF2DRD2SLC6A4 | |
| SCHEMBL23540460 | 0.89 | DDB1 (0.56) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL23540165 | 0.89 | DDB1 (0.56) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL23540806 | 0.89 | DDB1 (0.56) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL31323473 | 0.89 | DDB1 (0.56) | DDB1CRBNIKZF2DRD2SLC6A4 | |
| SCHEMBL30289127 | 0.89 | DDB1 (0.56) | DDB1CRBNIKZF2DRD2SLC6A4 | |
| SCHEMBL31333960 | 0.89 | DDB1 (0.54) | DDB1CRBNIKZF2DRD2SLC6A4 | |
| SCHEMBL31323537 | 0.89 | DDB1 (0.63) | DDB1CRBNIKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4405359-A2 | MDM2 DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| WO-2023049790-A2 | MDM2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-03-30 | — | — | WO | disclosed |